APA (7th ed.) Citation

HRB, B., CH, S., P, L., NJ, R., DB, P., M, L., . . . ZZN, Y. (2026). Serious infection risk with systemic treatments for psoriasis: A cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). The British journal of dermatology, 195(2), 261. https://doi.org/10.1093/bjd/ljag174

Chicago Style (17th ed.) Citation

HRB, Bright, Smith CH, Laws P, Reynolds NJ, Phan DB, Lunt M, Warren RB, and Yiu ZZN. "Serious Infection Risk with Systemic Treatments for Psoriasis: A Cohort Study from the British Association Of Dermatologists Biologics and Immunomodulators Register (BADBIR)." The British Journal of Dermatology 195, no. 2 (2026): 261. https://doi.org/10.1093/bjd/ljag174.

MLA (9th ed.) Citation

HRB, Bright, et al. "Serious Infection Risk with Systemic Treatments for Psoriasis: A Cohort Study from the British Association Of Dermatologists Biologics and Immunomodulators Register (BADBIR)." The British Journal of Dermatology, vol. 195, no. 2, 2026, p. 261, https://doi.org/10.1093/bjd/ljag174.